Michael Milos Thornton insider trades: ENDRA Life Sciences (NDRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2023 | NDRA | ↑ Buy | 15,000 | $1.65 | $25K | Direct | May 22, 2023 (4d) |
| Dec 9, 2022 | NDRA | ↑ Buy | 1,500 | $3.40 | $5K | Direct | Dec 13, 2022 (4d) |
| Aug 22, 2022 | NDRA | ↑ Buy | 20,000 | $0.27 | $5K | Direct | Aug 24, 2022 (2d) |
| May 26, 2022 | NDRA | ↑ Buy | 25,000 | $0.21 | $5K | Direct | May 31, 2022 (5d) |
| May 18, 2022 | NDRA | ↑ Buy | 25,000 | $0.22 | $6K | Direct | May 23, 2022 (5d) |
| Apr 7, 2021 | NDRA | ↓ Sell | 33,750 | $2.44 | $82K | Direct | Apr 7, 2021 (0d) |
| May 16, 2019 | NDRA | ↑ Buy | 30,000 | $1.13 | $34K | Direct | May 20, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael Milos Thornton's insider trades
Michael Milos Thornton is Chief Technology Officer at ENDRA Life Sciences (NDRA). Since May 16, 2019, Michael has reported 6 open-market purchases worth $80K and 1 sale worth $82K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), conversions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NDRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.